New Two-Pronged attack tested for Tough-to-Treat lung cancer
NCT ID NCT07489703
Summary
This study is testing whether a combination of two newer drugs can help control advanced non-small cell lung cancer that has specific genetic features (HER2 abnormalities). It will enroll about 30 adults, including those who have already tried standard treatment and those who have not. The goal is to see if this drug pair can slow cancer growth and is safe for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.